Eric Woo
Founder
AminoChain
AminoChain provides decentralized infrastructure for transparent and trusted research by connecting participants, samples, and data. The platform features a Specimen Center for searching harmonized biorepository inventories and a Donor Platform for participant engagement and consent management. This ecosystem ensures auditable consent, faster discovery of research-ready samples, and cryptographic provenance across all research assets.
- Biotechnology
- Enterprise Software
- Healthcare Technology
- Software Only
Updated 1 month ago
Funding
Raised to date
$7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
$5M across 1 disclosed round
+2$5M · Seed
Announced Sep 2024 · from article date
Disclosed cumulative: $5M
Reported total $7M
Incomplete round history. $2M of the $7M reported total isn’t matched to a known round.
RoundDateAmountValuationInvestors
Founders
Product
Problem
The procurement of biosamples and sharing of research data in healthcare is often inefficient due to fragmented inventory management and a lack of unified platforms for collaboration between researchers and donors. This can lead to delays in research, increased costs, and limited access to critical biosamples.
Solution
AminoChain provides a platform designed to streamline the handling of biosamples by connecting data across healthcare companies. The platform facilitates the connection of worldwide inventories of biosamples and research data, aiming to power the next generation of pre-clinical research economies. It allows users to query sample and data collections, maintain ownership of assets and intellectual property, and build a network of collaborators. The SpecimenCenter unifies sample procurement end-to-end, enabling users to connect with collaborators, search for available samples, reach agreements, and handle payments within a single platform.
Target Audience
The primary target audience includes healthcare companies, researchers, and biobanks involved in pre-clinical research and biosample procurement.
Features
- Unified platform for connecting bio-sample and research data inventories.
- Tools for adding users to query sample and data collections.
- Features to maintain ownership of assets and intellectual property.
- SpecimenCenter for end-to-end sample procurement.
- Search functionality for available samples.
- Platform to reach agreements and handle payments.